The outcome of patients with primary sclerosing cholangitis remains a controversial issue, although two survival studies, involving over 100 patients each, reported that the median survival was 12 years and that one-third of patients died or underwent liver transplantation. Clinical, laboratory and histological features have been shown to be prognostically significant in multivariate analyses.